Napoli Shkolnik, PLLC is currently investigating claims on behalf of patients who have suffered serious side effects from diabetes type 2 Tradjenta medication.
If you or a loved one was diagnosed with pancreatic cancer or thyroid cancer during or after taking Tradjenta or any other diabetes medications in this class of drugs, such as Januvia or Byetta, now is the time to talk to a pharmaceutical (drug) attorney at our firm. We can advise you of your options in seeking financial compensation for your injuries.
What is Tradjenta
Tradjenta is a type of medication that, along with diet and exercise, is designed to treat Type II diabetes. The active ingredient in Tradjenta is linagliptin, which belongs to a class of drugs known as DPP-4 inhibitors. The drug has been involved in several lawsuits, and research has linked taking Tradjenta with serious health concerns.
RISKS ASSOCIATED WITH TAKING TRADJENTA MEDICATION
Tradjenta is a newer diabetic medication (aka tradjenta diabetes) approved by the Food and Drug Administration (FDA) in 2011 as an add-on therapy to insulin in adult patients with Type 2 diabetes. It is marketed by Boehringer Ingelheim and Eli Lilly. The active pharmaceutical ingredient in Tradjenta is linagliptin, which is in a class of drugs called incretin mimetics. This class of medications has been under scrutiny by the FDA, after a study showed that they may be linked to pre-cancerous changes in the pancreas.
The link between pancreatic cancer and Tradjenta has yet to be fully established and recognized by the FDA, but the agency is currently investigating the matter to determine whether the recent study indicating pre-cancerous cellular changes may indicate an increased risk of pancreatic cancer in incretin mimetic users. The study, conducted by researchers at the University of California, Los Angeles, involved a small number of pancreatic tissue samples from patients that died from unspecified causes. The FDA has requested additional information from the study’s researchers to conduct its own evaluation of the methodology used to collect and study the specimens. The agency has also requested the tissue samples used in the study.
Like other types of DPP-4 inhibitors, such as the medications Januvia and Byetta, taking Tradjenta can have serious side effects. Most severe, taking Tradjenta may increase a patient’s risk of developing pancreatic cancer or/and pancreatitis (inflammation of the pancreas). Pancreatic diseases can be painful, are debilitating, require intensive medical care, and may cause death.
Patients with thyroid cancer or pancreatic cancer face a tough road ahead. Treatment may involve surgery, chemotherapy and/or radiation therapy, all of which come with serious risks. Treatment is also expensive. When a patient is dealing with physical pain, financial difficulties and the very real possibility that his or her life may be at risk, the team at Napoli Shkolnik, PLLC stands ready to help. We seek justice on behalf of clients across the U.S. who have suffered because of the negligence or wrongdoing of pharmaceutical companies.
Side Effects of Tradjenta
Tradjenta thyroid cancer symptoms may include:
- Swelling in the neck
- Lump in the front of the neck
- Enlargement of the thyroid
- Change in voice or hoarseness
- Pain in the front of the neck that may stretch to the ears
- Breathing problems (the feeling that you are breathing through a straw)
- Cough that does not go away and is not caused by a cold
- Cough with blood
- Swallowing problems
Pancreatic cancer – Disease that originates in the tissues of the pancreas, an abdominal organ that produces such vital hormones as insulin, glucagon, somatostatin, and pancreatic polypeptide. Pancreatic cancer often has a poor long-term outlook, even when diagnosed in its early stages. The disease typically spreads rapidly and is hard to detect early on, which is a major reason why it’s a leading cause of cancer death among men and women in the United States. Signs and symptoms of
Tradjenta-induced pancreatic cancer may include:
- Loss of appetite
- Weight loss
- Jaundice (yellowing of the skin and eyes)
Thyroid cancer – Disease of the thyroid gland, a butterfly-shaped organ located at the base of the neck. Most cases of thyroid cancer can be cured with treatment if they are detected early enough.
WHO IS LIABLE IF I HAVE SUFFERED?
The makers of Tradjenta, Eli Lilly & Co. and Boehringer Ingelheim, may be held liable for damages incurred due to taking Tradjenta, based on evidence that the companies did not fully disclose risks associated with taking Tradjenta. In addition to drug’s manufacturers, other parties who you may be able to file a lawsuit against, depending upon circumstances, include:
- The doctor who prescribed the medication;
- The pharmacist who filled the medication; or
- The hospital/pharmacy, where the prescription was written or/and filled.
A consultation with a defective drug attorney can help you to learn more.
PROTECT YOUR RIGHT TO COMPENSATION BY TAKING ACTION TODAY
Each state imposes a statute of limitations on defective product claims, which limits the amount of time you have to file a civil action. With offices in multiple states throughout the US. Napoli Shkolnik, PLLC is experienced defending clients as Tradjenta diabetes attorneys. We can help to ensure that your claim is filed properly and you have the legal representation you need to succeed. To learn more about whether you have a case and a right to recover damages, schedule a consultation with our lawyers by calling us today at 212-397-1000.
Seek Legal Counsel Today
With more than 150 years of combined experience among our trial attorneys and more than $3 billion in recoveries, we are a formidable opponent – even when faced with a pharmaceutical giant like Eli Lilly. Contact a pharmaceutical litigation attorney at our offices for a free consultation and review of your case. There is no risk; you pay no up-front fees and we only get paid if we negotiate a settlement or win a jury award on your behalf. Call today!